Find the Perfect Plan for Your Investment Journey
G
Latest price
52 Week Range
CA$0.43 - CA$1.15
Next Earnings Date
May 13 2025
Next Earnings Date
May 13 2025
Latest price
Market Cap | CA$122.74M |
EV | CA$130.02M |
Shares Outstanding | 236.54M |
Beta | -0.54 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | 42.30% |
EPS | -39.20% |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | -84.14% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
G
Grown Rogue International Inc.
GRIN
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Strickler, J.
Employees
Website
www.grownrogue.comIPO Date
2016-11-28
Headquarters
550 Airport Road, Medford, Oregon, 97504, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved